Penumbra is a healthcare company focusing on developing clinically beneficial products that aid patients suffering from stroke and other neurovascular diseases. Major products associated with the company include the Penumbra System, an ischemic stroke device platform; Penumbra Coil 400 for rapid aneurysm packing; 5MAX ACE, a clot extraction device; and Neuron System, a family of access catheters. The company was founded in 2004 and has its headquarters in Alameda, California.
Led by CEO Adam Elsesser, Penumbra operates in North and South America, Europe, Australia, and Asia. The company employs around 2,200 staff members and boasts an annual revenue of $847.1 million. Notably diverse, Penumbra's workforce consists of 40% female and 61.5% ethnic minorities. Employees at Penumbra earn competitive salaries, with an average annual wage of $60,007.